Pulsenmore

Executive Summary

Pulsenmore is an Israeli digital health company pioneering home-use ultrasound technology to enable remote maternal-fetal monitoring and other diagnostic applications. Founded in 2020 and based in Kfar Saba, the company has developed a portable ultrasound device that connects patients with healthcare providers via a dedicated platform, allowing for convenient at-home scans while maintaining clinical oversight. The device is designed for self-use by patients, with real-time guidance and cloud-based image analysis, reducing the need for in-person clinic visits. Pulsenmore has achieved commercial stage, indicating market traction and regulatory clearances, likely including CE marking or FDA clearance. The company addresses a growing demand for telehealth solutions, particularly in prenatal care, where frequent monitoring is essential. By enabling remote assessments, Pulsenmore can improve access to care, reduce costs, and enhance patient convenience. The platform also has potential beyond obstetrics, including general abdominal or cardiac imaging, though the current focus remains on pregnancy-related applications.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for expanded indications (e.g., fetal anatomy scan)75% success
• Q4 2026Strategic partnership with a major U.S. telehealth provider (e.g., Teladoc, Amwell)60% success
• Q2 2026Series B or C funding round to support commercial expansion80% success